Literature DB >> 30089252

Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21.

Lisa Michelle Restelli1, Björn Oettinghaus2, Mark Halliday3, Cavit Agca4, Maria Licci5, Lara Sironi1, Claudia Savoia6, Jürgen Hench2, Markus Tolnay2, Albert Neutzner4, Alexander Schmidt7, Anne Eckert8, Giovanna Mallucci9, Luca Scorrano10, Stephan Frank11.   

Abstract

Stress adaptation is essential for neuronal health. While the fundamental role of mitochondria in neuronal development has been demonstrated, it is still not clear how adult neurons respond to alterations in mitochondrial function and how neurons sense, signal, and respond to dysfunction of mitochondria and their interacting organelles. Here, we show that neuron-specific, inducible in vivo ablation of the mitochondrial fission protein Drp1 causes ER stress, resulting in activation of the integrated stress response to culminate in neuronal expression of the cytokine Fgf21. Neuron-derived Fgf21 induction occurs also in murine models of tauopathy and prion disease, highlighting the potential of this cytokine as an early biomarker for latent neurodegenerative conditions.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; autophagy; biomarker; endoplasmic reticulum; heme; metabolism; mitochondria; neurodegeneration; tau; unfolded protein response

Mesh:

Substances:

Year:  2018        PMID: 30089252      PMCID: PMC6092266          DOI: 10.1016/j.celrep.2018.07.023

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


Introduction

In neurons, mitochondrial fission, which in mammals depends mainly on dynamin-related protein Drp1, facilitates both axonal mitochondrial transport and mitophagic elimination (Oettinghaus et al., 2016, Pernas and Scorrano, 2016, Twig et al., 2008, Wai and Langer, 2016). Not surprisingly, Drp1 is therefore required for brain development and mature neuronal function (Berthet et al., 2014, Ishihara et al., 2009, Kageyama et al., 2012, Oettinghaus et al., 2016, Shields et al., 2015, Wakabayashi et al., 2009). In several clinically and pathologically distinct neurodegenerative diseases, mitochondrial morphology is disrupted (reviewed by DuBoff et al., 2013), substantiating the link among mitochondrial dynamics, function, and brain pathophysiology. Given this, brain mitochondrial dysfunction could represent an important marker to identify subjects at risk of developing neurodegenerative disorders, before neurological symptoms manifest; however, no surrogate marker of brain mitochondrial dysfunction is available. Mitochondria of peripheral organs (e.g., liver and muscle) can convey disruption of their function by mounting cell-wide stress responses (Cornu et al., 2014, Guridi et al., 2015, Hagiwara et al., 2012, Keipert et al., 2014, Kim et al., 2013a, Touvier et al., 2015, Tyynismaa et al., 2010). A common trait of these models is the expression, causally linked to mitochondrial dysfunction, of the metabolic cytokine fibroblast growth factor 21 (Fgf21). This cytokine exerts a plethora of tissue-specific effects and is subject to complex pharmacology and pharmacokinetics, aspects of which continue to be matter of debate (reviewed by Kharitonenkov and DiMarchi, 2017). In addition to being canonically produced by liver and white adipose tissue (WAT) in response to starvation, Fgf21 can be secreted by other organs, such as pancreas and brown adipose tissue (Degirolamo et al., 2016, Fisher and Maratos-Flier, 2016). Moreover, Fgf21 has been established as a marker of mitochondrial myopathies (Suomalainen et al., 2011, Tezze et al., 2017). Whether Fgf21 is also produced by the CNS in response to mitochondrial dysfunction is unknown. Here we capitalize on our previously generated mouse model of inducible mitochondrial fission ablation in mature forebrain neurons (Oettinghaus et al., 2016), as well as on bona fide mouse models of neurodegeneration, to demonstrate that various forms of neuronal cell stress, including mitochondrial dysfunction, are sensed by the integrated stress response (ISR). In each of these models, ISR activation leads to neuron-specific Fgf21 expression, highlighting the potential of this cytokine as biomarker for neurodegenerative conditions.

Results

Neuronal Drp1 Ablation Activates the ISR, Resulting in Fgf21 Induction

We previously generated a model of inducible ablation of the mitochondrial fission protein Drp1 in the adult mouse forebrain (Drp1; CaMKIIα::CreERT2, tamoxifen-inducible Drp1 deletion from brain, Drp1). In this model, neuronal Drp1 ablation compromised mitochondrial respiration and shifted cellular metabolism toward glycolysis (Oettinghaus et al., 2016); in addition, systemic catabolic changes occurred, which prompted further investigation. Because mitochondrial dysfunction in several peripheral organs can lead to the induction of the cytokine Fgf21 (Kharitonenkov and DiMarchi, 2015, Kim et al., 2013a, Suomalainen et al., 2011), we checked whether the same was true for a brain-specific mitochondrial defect. Starting 7 weeks post-tamoxifen injection (PTI, i.e., after Drp1 ablation), we found elevated Fgf21 plasma levels (Figure 1A), prompting us to investigate its source organ or organs. Subsequent analyses revealed that as early as 4 weeks after Drp1 ablation, Fgf21 transcription was induced specifically in hippocampus and cortex but not in: the cerebellum (where the Cre-driving CaMKIIα promoter is inactive); the canonical Fgf21 sources (liver and adipose tissue); or the skeletal muscle (Figure 1B). These results establish brain as the Fgf21 tissue source in our model. mRNA fluorescence in situ hybridization identified neurons as the primary Fgf21 producers in the Drp1-ablated mouse brain, shown in Figures 1C and 1D for the hippocampal CA1 region (Figures S1A–S1C detail the histological distribution of hippocampal pyramidal neurons for reference; for comparison, Figures S1D and S1E show the distribution of astrocytes and microglia). These observations are significant from two perspectives: we demonstrate that Fgf21 can be produced by neurons in response to mitochondrial dysfunction (Bookout et al., 2013, Suomalainen et al., 2011, Fon Tacer et al., 2010) and that Fgf21 produced in the brain can cross the blood-brain barrier (BBB) to become detectable in plasma (Kharitonenkov and DiMarchi, 2015).
Figure 1

Neuronal Drp1 Ablation Induces ISR-Driven Brain Fgf21 Expression

(A) FGF21 plasma levels in cardiac blood of Drp1-ablated and control mice. Positive control represents overnight-starved animals. Data represent average + SEM of at least 3 animals.

(B) qRT-PCR analysis of different mouse tissues at indicated time points PTI. Fgf21 mRNA ct values normalized against 18S rRNA ct values. Data represent average + SEM of at least 4 animals.

(C and D) Representative Fgf21 mRNA-fluorescence in situ hybridization (FISH) analysis of the hippocampal CA1 region of a Drp1-ablated mouse at 10 weeks PTI (C). Fgf21 mRNA hybridization signals are in green; nuclei are DAPI stained. Scale bar, 20 μm. Quantification of hybridization signals (D).

(E) Representative western blots of Drp1-ablated and control hippocampal lysates separated by SDS-PAGE and immunoblotted using indicated antibodies.

(F and G) Quantification of phosphorylated elF2α band intensity normalized to total elF2α (F) and Atf4 intensity normalized to actin (G). Data represent average + SEM of at least 4 animals.

(H) qRT-PCR analysis of Chop expression in various mouse brain regions. Data represent average + SEM of at least 4 animals.

Neuronal Drp1 Ablation Induces ISR-Driven Brain Fgf21 Expression (A) FGF21 plasma levels in cardiac blood of Drp1-ablated and control mice. Positive control represents overnight-starved animals. Data represent average + SEM of at least 3 animals. (B) qRT-PCR analysis of different mouse tissues at indicated time points PTI. Fgf21 mRNA ct values normalized against 18S rRNA ct values. Data represent average + SEM of at least 4 animals. (C and D) Representative Fgf21 mRNA-fluorescence in situ hybridization (FISH) analysis of the hippocampal CA1 region of a Drp1-ablated mouse at 10 weeks PTI (C). Fgf21 mRNA hybridization signals are in green; nuclei are DAPI stained. Scale bar, 20 μm. Quantification of hybridization signals (D). (E) Representative western blots of Drp1-ablated and control hippocampal lysates separated by SDS-PAGE and immunoblotted using indicated antibodies. (F and G) Quantification of phosphorylated elF2α band intensity normalized to total elF2α (F) and Atf4 intensity normalized to actin (G). Data represent average + SEM of at least 4 animals. (H) qRT-PCR analysis of Chop expression in various mouse brain regions. Data represent average + SEM of at least 4 animals.

The ISR Is Activated upon Neuronal Drp1 Ablation

We next wished to understand how mitochondrial dysfunction led to neuronal Fgf21 transcription. Among the transcription factors known to control Fgf21 expression, only Atf4 was upregulated in Drp1-ablated brains (Figure S2A). Atf4 translation is activated by phosphorylated eukaryotic translation initiation factor 2α (eIF2α), a crucial node in the ISR, responding to different forms of stress via decreased global translation and activation of transcriptional programs aimed at damage control (Donnelly et al., 2013). Western blot analysis confirmed Atf4 increase and eIF2α phosphorylation in Drp1 hippocampi (Figures 1E–1G). The canonical Atf4 target gene Chop (Ddit3 or Gadd153) was accordingly upregulated in Drp1 hippocampus and cortex (Figure 1H). Furthermore, proteomics revealed that Atf4 target genes were significantly enriched in Drp1 brains (Figure S2B). Four eIF2α kinases are capable of sensing specific ISR-triggering stress conditions: Perk responds to endoplasmic reticulum (ER) stress; Gcn2 acts as sensor for amino acid deficiency activated by uncharged tRNAs; Pkr senses double-stranded RNAs to signal viral infections and transduces the mitochondrial unfolded protein response (mtUPR) (Rath et al., 2012); and HRI becomes activated in the absence of heme (Donnelly et al., 2013). In vivo, the eIF2α-phosphorylating arm or arms of the ISR could not be detected by direct immunoblot (due to paucity of their expression and the mixed cellular nature of brain lysates). However, we investigated the specific upstream stress or stresses triggering the Fgf21-inducing cascade as a proxy for their respective ISR arm activation. The close apposition of ER and mitochondria favors ER stress upon loss of proteins involved in mitochondrial and ER morphology regulation (de Brito and Scorrano, 2008, Muñoz et al., 2013). Drp1 was originally identified as a modulator of mitochondrial, as well as ER shape (Pitts et al., 1999, Yoon et al., 1998), suggesting that its deletion might also affect the ER. Electron microscopy (EM) of hippocampi 4 weeks PTI revealed that the ER was round and swollen, unlike the flat ER cisternae in the Drp1 counterparts (Figure 2A). In addition, the ER stress marker Bip/GRP78 was upregulated in Drp1 brains at later stages (Figures 2B and 2C), pointing to a link between neuronal Drp1 deletion and ER stress activation. As a proof of principle, when we intraventricularly injected wild-type mice with the ER stress inducer tunicamycin, we noticed not only an activated unfolded protein response (UPR), as reflected by eIF2α phosphorylation and Atf4 elevation, but also an increase in Fgf21 mRNA (Figures 2D–2F), leading to an elevation in plasma Fgf21 levels (Figure 2G). Altogether, these data indicate that Drp1 brains mount an UPR and that brain ER stress is sufficient to induce local Fgf21 expression and plasma Fgf21 elevation.
Figure 2

ER Stress Is Present and Sufficient for Fgf21 Induction upon Drp1 Ablation

(A) Representative transmission electron microscopy (TEM) images of ER (marked by black arrows) of hippocampal neurons of 4-week-Drp1-ablated and control mice. Scale bar, 1 μm.

(B) Bip and actin western blot on hippocampal lysates of mice of the indicated genotypes at 10 weeks PTI. This experiment shares a loading control with Figure 1E.

(C) Quantification of Bip band intensity normalized to actin. Data represent average + SEM of at least 4 animals.

(D–G) Markers of ER stress and Fgf21 levels in brain tissue and plasma following intraventricular tunicamycin (TUM) injection.

(D) Fgf21 mRNA in TUM- and Sham-injected hippocampi.

(E and F) Representative western blot (E) and quantification (F) of TUM- and Sham-injected hippocampal lysates probed for the indicated proteins. Data represent average + SEM of at least 3 animals.

(G) Fgf21 plasma levels as determined by ELISA. Data represent average + SEM of at least 5 animals.

ER Stress Is Present and Sufficient for Fgf21 Induction upon Drp1 Ablation (A) Representative transmission electron microscopy (TEM) images of ER (marked by black arrows) of hippocampal neurons of 4-week-Drp1-ablated and control mice. Scale bar, 1 μm. (B) Bip and actin western blot on hippocampal lysates of mice of the indicated genotypes at 10 weeks PTI. This experiment shares a loading control with Figure 1E. (C) Quantification of Bip band intensity normalized to actin. Data represent average + SEM of at least 4 animals. (D–G) Markers of ER stress and Fgf21 levels in brain tissue and plasma following intraventricular tunicamycin (TUM) injection. (D) Fgf21 mRNA in TUM- and Sham-injected hippocampi. (E and F) Representative western blot (E) and quantification (F) of TUM- and Sham-injected hippocampal lysates probed for the indicated proteins. Data represent average + SEM of at least 3 animals. (G) Fgf21 plasma levels as determined by ELISA. Data represent average + SEM of at least 5 animals.

The ER Stress Component Is Dispensable for Fgf21 Induction

To understand whether ER stress was necessary to induce Fgf21 expression, we capitalized on the orally bioavailable chemical chaperone tauroursodeoxycholic acid (TUDCA), which reduces mitochondria-induced ER stress in flies and mice (Debattisti et al., 2014, Muñoz et al., 2013). Co-treatment of Drp1 mice with TUDCA and tamoxifen resulted in lower Bip and P-eIF2α levels, confirming TUDCA bioavailability and activity in the brain. However, eIF2α phosphorylation and expression of Fgf21, as well as of the canonical Atf4 target gene Chop, remained elevated in TUDCA-treated Drp1 mice (Figures 3A–3E).
Figure 3

ER Stress-Independent ISR Branches Contribute to Fgf21 Induction

(A–E) Analysis of TUDCA-treated Drp1-ablated and control mice.

(A) Representative western blots of hippocampal lysates of the indicated genotype 10 weeks PTI, probed for Bip, P-eIF2α, total eIF2α, Atf4, and actin.

(B and C) Quantification of Bip (B) and phosphorylated elF2α (C) band intensities normalized to actin (Bip) or total eIF2α, respectively.

(D and E) Hippocampal Fgf21 (D) and Chop (E) mRNA expression determined by qRT-PCR, normalized to 18S rRNA ct values. Data represent average + SEM of at least 4 animals.

(F) Free amino acids in the indicated brain regions 10 weeks PTI. Data represent average ± SEM of at least 4 animals.

(G) Fold change in selected hits of a total proteomics screen 10 weeks PTI, plotted as a function of the respective q value.

(H) Fold change in selected, iron-related hits of a proteomics screen 10 weeks PTI.

Asterisks in (E) denote q values (i.e., p values adjusted for multiple testing): ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

ER Stress-Independent ISR Branches Contribute to Fgf21 Induction (A–E) Analysis of TUDCA-treated Drp1-ablated and control mice. (A) Representative western blots of hippocampal lysates of the indicated genotype 10 weeks PTI, probed for Bip, P-eIF2α, total eIF2α, Atf4, and actin. (B and C) Quantification of Bip (B) and phosphorylated elF2α (C) band intensities normalized to actin (Bip) or total eIF2α, respectively. (D and E) Hippocampal Fgf21 (D) and Chop (E) mRNA expression determined by qRT-PCR, normalized to 18S rRNA ct values. Data represent average + SEM of at least 4 animals. (F) Free amino acids in the indicated brain regions 10 weeks PTI. Data represent average ± SEM of at least 4 animals. (G) Fold change in selected hits of a total proteomics screen 10 weeks PTI, plotted as a function of the respective q value. (H) Fold change in selected, iron-related hits of a proteomics screen 10 weeks PTI. Asterisks in (E) denote q values (i.e., p values adjusted for multiple testing): ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Overall, although ER stress is present in Drp1 brains and can cause Fgf21 expression, its inhibition alone is not sufficient to abolish Fgf21 in our model, suggesting that one or more of the alternative ISR branches contribute to the observed phenotype.

Impaired Amino Acid and Iron Metabolism Contributes to ISR-Driven Fgf21 Induction

To understand which mechanism accounted for Fgf21 production, we explored the role of the mitochondrial bioenergetics defect caused by Drp1 ablation (Oettinghaus et al., 2016). However, at 10 weeks PTI, protein levels of Hsp60 and mRNA levels of Hsp10, ClpP, and Yme1l, markers of the mtUPR, were normal in Drp1 brains (Figures S3A–S3C). We confirmed this by an unbiased proteomic analysis on pooled hippocampi and cortices from mice 10 weeks PTI: mtUPR was not in place in Drp1 mice, with three of the five acknowledged mtUPR genes even significantly decreased (Figure S3D). Alternatively, ISR could result from a defect in amino acid biosynthesis or catabolism, both crucially located at the mitochondrial level. Total amino acid content was moderately decreased in the hippocampus, whereas amino acids were significantly increased in the cortex of Drp1 mice (Figure 3F). In addition, aminoacyl-tRNA synthetases were significantly enriched hits of the proteomics analysis of Drp1 brains. Even more remarkable was the signature of the subcellular distribution of the altered aminoacyl-tRNA synthetases: 80% of cytosolic aminoacyl-tRNA synthetases were significantly upregulated in Drp1 brains, while their mitochondrial counterparts were mostly downregulated (Figure 3G). Because heme biosynthesis depends on amino acid metabolism, as well as on mitochondrial function (Lane et al., 2015), we next wanted to check its potential involvement in the phenotype. Ferrochelatase, a rate-limiting mitochondria-localized component of the heme biosynthetic pathway, was downregulated in Drp1 mice, as was mitochondrial matrix iron metabolism regulator frataxin (Figure 3H). Accordingly, cytosolic iron storage protein ferritin H was upregulated, and iron importer transferrin receptor was downregulated in Drp1 brains. Finally, heme-containing hemoglobin was also strongly downregulated in Drp1 brains (Figure 3H), reflecting the global changes in iron metabolism caused by Drp1 ablation. Altogether, these data suggest that both amino acid metabolism and heme biosynthesis are altered upon Drp1 ablation and may contribute to ISR activation in Drp1 mice.

Brain-Derived Fgf21 Is Induced in Two Etiologically Distinct Mouse Models of Neurodegeneration

We next wished to investigate the possibility that Fgf21 was induced in clinically relevant models of brain pathologies affecting mitochondrial dynamics and function. To this end, we examined tau-mutated P301L mice, a model of frontotemporal dementia (FTD) (Lewis et al., 2000), as well as the tg37-Rocky Mountain Laboratory (RML) prion inoculation model (Mallucci et al., 2003, Moreno et al., 2013). Both models display ISR that responds to PERK inhibition (Moreno et al., 2013, Radford et al., 2015), as well as defects in mitochondrial function and transport (Choi et al., 2014, Chou et al., 2011). In both models, the ER stress and ISR activation markers Bip, P-eIF2α, and Atf4 were upregulated (Figures 4A–4C, 4E, and 4F). Fgf21 mRNA was elevated in hippocampi of P301L, as well as of prion-injected mice at different time points, also before the onset of symptoms (Figures 4D and 4H). Prion-inoculated mice orally treated with PERK inhibitor GSK2606414 showed a demonstrable decrease in Fgf21 expression, confirming that Fgf21 induction is ER stress dependent (Figure 4H). Thus, Fgf21 transcription is induced in etiologically distinct mouse models of neurodegeneration not caused by a primary mitochondrial defect. Our data collectively indicate that Fgf21 might be an early biomarker for neurodegenerative processes associated with mitochondrial dysfunction and ISR activation.
Figure 4

Brain-Derived Fgf21 Is Induced in Mouse Models of Neurodegeneration

Data from P301L tau mutant mice (A–D) and RML prion inoculation disease model (E–H).

(A) Western blot of hippocampi of 9-month-old P301L mutant mice and age-matched controls.

(B and C) Quantification of Bip (B) and Atf4 (C) band intensities, normalized to their respective loading control.

(D) Hippocampal Fgf21 mRNA expression of 9-month-old P301L mutant mice and age-matched controls, determined by qRT-PCR. Data represent average + SEM of at least 4 animals.

(E) Western blot of hippocampi of mice intracerebrally inoculated with RML prions at 10 weeks postinoculation (wpi).

(F and G) Quantification of Bip (F) and Atf4 (G) band intensities normalized to their respective loading control.

(H) Fgf21 transcript levels in hippocampi of normal brain homogenate (NBH) or RML prion-inoculated mice at 6, 8, and 10 wpi. Data represent average + SEM of at least 8 animals.

Brain-Derived Fgf21 Is Induced in Mouse Models of Neurodegeneration Data from P301L tau mutant mice (A–D) and RML prion inoculation disease model (E–H). (A) Western blot of hippocampi of 9-month-old P301L mutant mice and age-matched controls. (B and C) Quantification of Bip (B) and Atf4 (C) band intensities, normalized to their respective loading control. (D) Hippocampal Fgf21 mRNA expression of 9-month-old P301L mutant mice and age-matched controls, determined by qRT-PCR. Data represent average + SEM of at least 4 animals. (E) Western blot of hippocampi of mice intracerebrally inoculated with RML prions at 10 weeks postinoculation (wpi). (F and G) Quantification of Bip (F) and Atf4 (G) band intensities normalized to their respective loading control. (H) Fgf21 transcript levels in hippocampi of normal brain homogenate (NBH) or RML prion-inoculated mice at 6, 8, and 10 wpi. Data represent average + SEM of at least 8 animals.

Discussion

Here, we report that Drp1 deletion from adult forebrain neurons in vivo triggers the activation of a multi-branched stress response culminating in brain Fgf21 expression. Impaired mitochondrial function is linked to Fgf21 production in various peripheral tissues, but not in brain (Cornu et al., 2014, Guridi et al., 2015, Hagiwara et al., 2012, Keipert et al., 2014, Kim et al., 2013a, Kim et al., 2013b, Touvier et al., 2015, Tyynismaa et al., 2010). In our system, Drp1 deletion impairs mitochondrial dynamics and ER morphology and induces ER stress (Figure 2). This could be due to alterations in mitochondria-ER contacts affecting the two organellar membranes, modifying membrane curvature and activating ER stress sensor PERK (Volmer et al., 2013), or due to direct Drp1 action on ER shape (Yoon et al., 1998). Lack of rescue by TUDCA treatment (Figures 3A–3E) indicates that additional stress pathways converging on eIF2α are activated in the brain upon Drp1 deletion. In particular, heme biosynthesis and amino acid metabolism, two mitochondria-related pathways, are affected by brain Drp1 ablation (Figures 3F–3H). Heme biosynthesis is a partially mitochondria-resident pathway that requires iron to be actively imported into the organelles, as well as amino acids as precursors. Therefore, given the compromised bioenergetic state of Drp1-ablated mitochondria, which could affect organellar iron import, it is plausible that intramitochondrial steps of heme biosynthesis are impaired. This is corroborated by the increase in cytosolic ferritin H and the decrease in transferrin receptor (a signature of high cytosolic iron) (Muckenthaler et al., 2008). The stark decrease of two hemoglobin subunits, which would bind heme, is also in line with the heme deprivation hypothesis (Figure 3H) (Chen, 2007, Han et al., 2001). Different brain regions display differential sensitivity to Drp1 deletion, reflecting their individual metabolic needs and responses (Berthet et al., 2014, Kageyama et al., 2012, Oettinghaus et al., 2016, Shields et al., 2015). One explanation can lie in the ability of Atf4 to act with other transcription factors in a combinatorial manner based on the nature of the stress (Kilberg et al., 2009). Total amino acid concentration varied drastically between hippocampus and cortex (Figure 3F), which could be linked to the presence, in the anterior piriform cortex, of the body’s amino acid deficiency sensor (Anthony and Gietzen, 2013). It is therefore conceivable that the differential sensitivity to Drp1 ablation is linked to the different degrees of amino acid concentration changes within the brain. The importance of Fgf21 as a proxy of brain mitochondrial defects is reinforced by the finding that Fgf21 is expressed in brains of prion-inoculated mice, as well as of mice carrying the FTD-associated P301L tau mutation (Figures 4D and 4H). Similar to Drp1-deleted mice, both models display defects in mitochondrial function and transport, as well as ER stress-dependent ISR activation that can be reversed by PERK blockage (Chou et al., 2011, Radford et al., 2015). Although dysregulated iron and heme have also been linked to tau accumulation and prion diseases (Belaidi and Bush, 2016, Singh, 2014), ISR activation in these models is exclusively PERK dependent, which makes them an ideal model to study the reversal of Fgf21 expression by GSK2606414. Fgf21 is regulated by circadian and nutritional factors (Fisher and Maratos-Flier, 2016, Kharitonenkov and DiMarchi, 2017), potentially limiting the specificity of its detection in vivo as a biomarker of neuronal mitochondrial dysfunction. In particular, liver Fgf21 production is modulated by diverse dietary manipulations beyond fasting (Fisher and Maratos-Flier, 2016). For these reasons, the exploration of Fgf21 levels in patients' samples was beyond the scope of this work. Nevertheless, in light of our findings and of Fgf21 being a biomarker of mitochondrial myopathies, we encourage clinicians to explore this possibility in existing, appropriately controlled patient cohorts. Of course, confounding factors such as diabetes, obesity, or liver disease shall be carefully considered. To this end, cerebrospinal fluid (CSF) analyses might prove relevant, although at least upon its acute peripheral injection in mice, this cytokine can also cross the BBB (Douris et al., 2015, Hsuchou et al., 2007). Future work grounded in the discoveries reported here will test whether Fgf21 is induced in other diseases sharing mitochondrial and ER stress components, like Parkinson’s disease and disorders of the amyotrophic lateral sclerosis/FTD spectrum (Stoica et al., 2014, Wang et al., 2016a, Wang et al., 2016b). While we do not expect Fgf21 to aid in the diagnostic discrimination of different neurodegenerative entities, we can predict that our discovery of a secreted, brain-derived factor induced in etiologically diverse CNS diseases would represent a much-needed progress in presymptomatic screening, within a combined framework of validated biomarkers and predictive algorithms. In conclusion, our work shows that neurons sense dysregulated mitochondrial dynamics and ER stress to activate a multi-branched stress response culminating in the release of Fgf21. The same Fgf21 mitokine is produced in the brains of bona fide tauopathy and prion disease mouse models, highlighting its potential as a marker of brain mitochondrial dysfunction.

Experimental Procedures

For more details, refer to the Supplemental Experimental Procedures.

Mice

Drp1 and tau mutant (P301L) mice were described previously (Oettinghaus et al., 2016, Lewis et al., 2000, Radford et al., 2015). For the prion disease model, hemizygous tg37 mice inoculated with RML prion were used (Mallucci et al., 2003, Moreno et al., 2013).

Western Blot

Lysates of perfused mouse brains were analyzed as previously described (Oettinghaus et al., 2016). Antibodies are listed in Supplemental Experimental Procedures.

Real-Time PCR

Organs were collected from PBS-perfused mice and RNA was isolated (RNeasy kits 74104, 74704, and 74804). RT-PCR was performed using the High Capacity cDNA Reverse Transcription Kit (Invitrogen, 4368814). Real-time PCR was performed using TaqMan assays (Life Technologies) on a 7900HT Real-Time PCR System (Applied Biosystems). TaqMan assays are listed in Supplemental Experimental Procedures. Cross-threshold (ct) values were normalized to 18S ct values.

Fluorescent Detection of Fgf21 mRNA

This analysis was performed as a service by Advanced Cell Diagnostics with the RNAscope technology, following the standard manufacturer’s protocol.

ELISA

Blood was collected between 9 and 10 a.m., and plasma Fgf21 levels were analyzed according to the manufacturer’s instructions (BioVendor, RD291108200R).

Quantitative Proteomics

Details on this analysis were described previously (Oettinghaus et al., 2016). Data are available via ProteomeXchange: PXD004890.

Statistics

Data analysis was performed with GraphPad Prism 6. For statistical analyses, two-tailed Student’s t test and one-way ANOVA with Sidak’s multiple comparison corrections were used. Unless otherwise specified, asterisks denote p values of an unpaired, two-tailed Student’s t test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
  53 in total

Review 1.  Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function.

Authors:  Lena Pernas; Luca Scorrano
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

2.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Authors:  Klementina Fon Tacer; Angie L Bookout; Xunshan Ding; Hiroshi Kurosu; George B John; Lei Wang; Regina Goetz; Moosa Mohammadi; Makoto Kuro-o; David J Mangelsdorf; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2010-07-28

3.  Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.

Authors:  Marion Cornu; Wolfgang Oppliger; Verena Albert; Aaron M Robitaille; Francesca Trapani; Luca Quagliata; Tobias Fuhrer; Uwe Sauer; Luigi Terracciano; Michael N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

Review 4.  Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network.

Authors:  Martina U Muckenthaler; Bruno Galy; Matthias W Hentze
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

5.  Mfn2 modulates the UPR and mitochondrial function via repression of PERK.

Authors:  Juan Pablo Muñoz; Saška Ivanova; Jana Sánchez-Wandelmer; Paula Martínez-Cristóbal; Eduard Noguera; Ana Sancho; Angels Díaz-Ramos; María Isabel Hernández-Alvarez; David Sebastián; Caroline Mauvezin; Manuel Palacín; Antonio Zorzano
Journal:  EMBO J       Date:  2013-08-06       Impact factor: 11.598

Review 6.  Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.

Authors:  Abdel A Belaidi; Ashley I Bush
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

7.  The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice.

Authors:  Junko Wakabayashi; Zhongyan Zhang; Nobunao Wakabayashi; Yasushi Tamura; Masahiro Fukaya; Thomas W Kensler; Miho Iijima; Hiromi Sesaki
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

8.  Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation.

Authors:  T Touvier; C De Palma; E Rigamonti; A Scagliola; E Incerti; L Mazelin; J-L Thomas; M D'Antonio; L Politi; L Schaeffer; E Clementi; S Brunelli
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

9.  Synaptic dysfunction, memory deficits and hippocampal atrophy due to ablation of mitochondrial fission in adult forebrain neurons.

Authors:  B Oettinghaus; J M Schulz; L M Restelli; M Licci; C Savoia; A Schmidt; K Schmitt; A Grimm; L Morè; J Hench; M Tolnay; A Eckert; P D'Adamo; P Franken; N Ishihara; K Mihara; J Bischofberger; L Scorrano; S Frank
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

10.  Reduction of endoplasmic reticulum stress attenuates the defects caused by Drosophila mitofusin depletion.

Authors:  Valentina Debattisti; Diana Pendin; Elena Ziviani; Andrea Daga; Luca Scorrano
Journal:  J Cell Biol       Date:  2014-01-27       Impact factor: 10.539

View more
  37 in total

1.  Mitochondrial retrograde signalling in neurological disease.

Authors:  Lucy Granat; Rachel J Hunt; Joseph M Bateman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

Review 2.  Systemic effects of mitochondrial stress.

Authors:  Raz Bar-Ziv; Theodore Bolas; Andrew Dillin
Journal:  EMBO Rep       Date:  2020-05-24       Impact factor: 8.807

Review 3.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

4.  Rapamycin attenuates liver injury caused by vinyl chloride metabolite chloroethanol and lipopolysaccharide in mice.

Authors:  Anna L Lang; Austin M Krueger; Regina D Schnegelberger; Brenna R Kaelin; Maxwell J Rakutt; Liya Chen; Gavin E Arteel; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2019-09-06       Impact factor: 4.219

Review 5.  The cell biology of mitochondrial membrane dynamics.

Authors:  Marta Giacomello; Aswin Pyakurel; Christina Glytsou; Luca Scorrano
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-18       Impact factor: 94.444

6.  Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses.

Authors:  Isabella R Straub; Woranontee Weraarpachai; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2021-05-17       Impact factor: 6.150

Review 7.  Metabolic Messengers: FGF21.

Authors:  Kyle H Flippo; Matthew J Potthoff
Journal:  Nat Metab       Date:  2021-03-18

8.  Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging.

Authors:  Maria Conte; Jacopo Sabbatinelli; Antonio Chiariello; Morena Martucci; Aurelia Santoro; Daniela Monti; Marina Arcaro; Daniela Galimberti; Elio Scarpini; Anna Rita Bonfigli; Angelica Giuliani; Fabiola Olivieri; Claudio Franceschi; Stefano Salvioli
Journal:  Geroscience       Date:  2020-10-31       Impact factor: 7.713

Review 9.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

10.  Severe protein deficiency induces hepatic expression and systemic level of FGF21 but inhibits its hypothalamic expression in growing rats.

Authors:  Joanna Moro; Catherine Chaumontet; Patrick C Even; Anne Blais; Julien Piedcoq; Claire Gaudichon; Daniel Tomé; Dalila Azzout-Marniche
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.